olmesartan has been researched along with glyburide in 2 studies
Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (glyburide) | Trials (glyburide) | Recent Studies (post-2010) (glyburide) |
---|---|---|---|---|---|
841 | 185 | 554 | 6,554 | 620 | 1,344 |
Protein | Taxonomy | olmesartan (IC50) | glyburide (IC50) |
---|---|---|---|
ATP-binding cassette sub-family C member 9 | Homo sapiens (human) | 0.22 | |
Bile salt export pump | Rattus norvegicus (Norway rat) | 5.7 | |
Bile salt export pump | Homo sapiens (human) | 5.5333 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 1.602 | |
ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | 0.0043 | |
ATP-sensitive inward rectifier potassium channel 11 | Homo sapiens (human) | 0.1121 | |
NACHT, LRR and PYD domains-containing protein 3 | Mus musculus (house mouse) | 10 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
1 review(s) available for olmesartan and glyburide
Article | Year |
---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
1 other study(ies) available for olmesartan and glyburide
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |